Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodies.

Goldstein LD, Chen YJ, Wu J, Chaudhuri S, Hsiao YC, Schneider K, Hoi KH, Lin Z, Guerrero S, Jaiswal BS, Stinson J, Antony A, Pahuja KB, Seshasayee D, Modrusan Z, Hötzel I, Seshagiri S.

Commun Biol. 2019 Aug 9;2(1):304. doi: 10.1038/s42003-019-0551-y.

PMID:
31925129
2.

Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodies.

Goldstein LD, Chen YJ, Wu J, Chaudhuri S, Hsiao YC, Schneider K, Hoi KH, Lin Z, Guerrero S, Jaiswal BS, Stinson J, Antony A, Pahuja KB, Seshasayee D, Modrusan Z, Hötzel I, Seshagiri S.

Commun Biol. 2019 Aug 9;2:304. doi: 10.1038/s42003-019-0551-y. eCollection 2019.

3.

Massive antibody discovery used to probe structure-function relationships of the essential outer membrane protein LptD.

Storek KM, Chan J, Vij R, Chiang N, Lin Z, Bevers J 3rd, Koth CM, Vernes JM, Meng YG, Yin J, Wallweber H, Dalmas O, Shriver S, Tam C, Schneider K, Seshasayee D, Nakamura G, Smith PA, Payandeh J, Koerber JT, Comps-Agrar L, Rutherford ST.

Elife. 2019 Jun 25;8. pii: e46258. doi: 10.7554/eLife.46258.

4.

Immune repertoire mining for rapid affinity optimization of mouse monoclonal antibodies.

Hsiao YC, Shang Y, DiCara DM, Yee A, Lai J, Kim SH, Ellerman D, Corpuz R, Chen Y, Rajan S, Cai H, Wu Y, Seshasayee D, Hötzel I.

MAbs. 2019 May/Jun;11(4):735-746. doi: 10.1080/19420862.2019.1584517. Epub 2019 Mar 22.

PMID:
30900945
5.

Analysis of the effect of promoter type and skin pretreatment on antigen expression and antibody response after gene gun-based immunization.

Vij R, Lin Z, Schneider K, Seshasayee D, Koerber JT.

PLoS One. 2018 Jun 1;13(6):e0197962. doi: 10.1371/journal.pone.0197962. eCollection 2018.

6.

A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies.

Vij R, Lin Z, Chiang N, Vernes JM, Storek KM, Park S, Chan J, Meng YG, Comps-Agrar L, Luan P, Lee S, Schneider K, Bevers J 3rd, Zilberleyb I, Tam C, Koth CM, Xu M, Gill A, Auerbach MR, Smith PA, Rutherford ST, Nakamura G, Seshasayee D, Payandeh J, Koerber JT.

Sci Rep. 2018 May 8;8(1):7136. doi: 10.1038/s41598-018-25609-z.

7.

Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes.

Arenzana TL, Lianoglou S, Seki A, Eidenschenk C, Cheung T, Seshasayee D, Hagenbeek T, Sambandam A, Noubade R, Peng I, Lesch J, DeVoss J, Wu X, Lee WP, Caplazi P, Webster J, Liu J, Pham VC, Arnott D, Lill JR, Modrusan Z, Dey A, Rutz S.

Sci Immunol. 2018 Apr 20;3(22). pii: eaal1953. doi: 10.1126/sciimmunol.aal1953.

PMID:
29678836
8.

Monoclonal antibody targeting the β-barrel assembly machine of Escherichia coli is bactericidal.

Storek KM, Auerbach MR, Shi H, Garcia NK, Sun D, Nickerson NN, Vij R, Lin Z, Chiang N, Schneider K, Wecksler AT, Skippington E, Nakamura G, Seshasayee D, Koerber JT, Payandeh J, Smith PA, Rutherford ST.

Proc Natl Acad Sci U S A. 2018 Apr 3;115(14):3692-3697. doi: 10.1073/pnas.1800043115. Epub 2018 Mar 19.

9.

Erratum: Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation.

Wertz IE, Newton K, Seshasayee D, Kusam S, Lam C, Zhang J, Popovych N, Helgason E, Schoeffler A, Jeet S, Ramamoorthi N, Kategaya L, Newman RJ, Horikawa K, Dugger D, Sandoval W, Mukund S, Zindal A, Martin F, Quan C, Tom J, Fairbrother WJ, Townsend M, Warming S, DeVoss J, Liu J, Dueber E, Caplazi P, Lee WP, Goodnow CC, Balazs M, Yu K, Kolumam G, Dixit VM.

Nature. 2016 Apr 21;532(7599):402. doi: 10.1038/nature16541. Epub 2016 Jan 13. No abstract available.

PMID:
26760210
10.

Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation.

Wertz IE, Newton K, Seshasayee D, Kusam S, Lam C, Zhang J, Popovych N, Helgason E, Schoeffler A, Jeet S, Ramamoorthi N, Kategaya L, Newman RJ, Horikawa K, Dugger D, Sandoval W, Mukund S, Zindal A, Martin F, Quan C, Tom J, Fairbrother WJ, Townsend M, Warming S, DeVoss J, Liu J, Dueber E, Caplazi P, Lee WP, Goodnow CC, Balazs M, Yu K, Kolumam G, Dixit VM.

Nature. 2015 Dec 17;528(7582):370-5. doi: 10.1038/nature16165. Epub 2015 Dec 9. Erratum in: Nature. 2016 Apr 21;532(7599):402.

PMID:
26649818
11.

Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus.

Lin W, Seshasayee D, Lee WP, Caplazi P, McVay S, Suto E, Nguyen A, Lin Z, Sun Y, DeForge L, Balazs M, Martin F, Zarrin AA.

Arthritis Rheumatol. 2015 Jan;67(1):215-24. doi: 10.1002/art.38907.

12.

In vivo antigen-driven plasmablast enrichment in combination with antigen-specific cell sorting to facilitate the isolation of rare monoclonal antibodies from human B cells.

Lin Z, Chiang NY, Chai N, Seshasayee D, Lee WP, Balazs M, Nakamura G, Swem LR.

Nat Protoc. 2014 Jul;9(7):1563-77. doi: 10.1038/nprot.2014.104. Epub 2014 Jun 5.

PMID:
24901740
13.

Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation.

Choy DF, Hsu DK, Seshasayee D, Fung MA, Modrusan Z, Martin F, Liu FT, Arron JR.

J Allergy Clin Immunol. 2012 Dec;130(6):1335-43.e5. doi: 10.1016/j.jaci.2012.06.044. Epub 2012 Aug 22.

14.

Loss of the tumor suppressor BAP1 causes myeloid transformation.

Dey A, Seshasayee D, Noubade R, French DM, Liu J, Chaurushiya MS, Kirkpatrick DS, Pham VC, Lill JR, Bakalarski CE, Wu J, Phu L, Katavolos P, LaFave LM, Abdel-Wahab O, Modrusan Z, Seshagiri S, Dong K, Lin Z, Balazs M, Suriben R, Newton K, Hymowitz S, Garcia-Manero G, Martin F, Levine RL, Dixit VM.

Science. 2012 Sep 21;337(6101):1541-6. Epub 2012 Aug 9.

15.

Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis.

Hsu CL, Lin W, Seshasayee D, Chen YH, Ding X, Lin Z, Suto E, Huang Z, Lee WP, Park H, Xu M, Sun M, Rangell L, Lutman JL, Ulufatu S, Stefanich E, Chalouni C, Sagolla M, Diehl L, Fielder P, Dean B, Balazs M, Martin F.

Science. 2012 Jan 6;335(6064):89-92. doi: 10.1126/science.1213682. Epub 2011 Dec 15.

16.

The adaptor protein Sh2d3c is critical for marginal zone B cell development and function.

Al-Shami A, Wilkins C, Crisostomo J, Seshasayee D, Martin F, Xu N, Suwanichkul A, Anderson SJ, Oravecz T.

J Immunol. 2010 Jul 1;185(1):327-34. doi: 10.4049/jimmunol.1000096. Epub 2010 May 26.

17.

Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus.

Abbas AR, Wolslegel K, Seshasayee D, Modrusan Z, Clark HF.

PLoS One. 2009 Jul 1;4(7):e6098. doi: 10.1371/journal.pone.0006098.

18.

In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation.

Seshasayee D, Lee WP, Zhou M, Shu J, Suto E, Zhang J, Diehl L, Austin CD, Meng YG, Tan M, Bullens SL, Seeber S, Fuentes ME, Labrijn AF, Graus YM, Miller LA, Schelegle ES, Hyde DM, Wu LC, Hymowitz SG, Martin F.

J Clin Invest. 2007 Dec;117(12):3868-78.

19.

Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade.

Lin WY, Gong Q, Seshasayee D, Lin Z, Ou Q, Ye S, Suto E, Shu J, Lee WP, Lee CW, Fuh G, Leabman M, Iyer S, Howell K, Gelzleichter T, Beyer J, Danilenko D, Yeh S, DeForge LE, Ebens A, Thompson JS, Ambrose C, Balazs M, Starovasnik MA, Martin F.

Blood. 2007 Dec 1;110(12):3959-67. Epub 2007 Aug 8.

PMID:
17687108
20.

A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys.

Vugmeyster Y, Seshasayee D, Chang W, Storn A, Howell K, Sa S, Nelson T, Martin F, Grewal I, Gilkerson E, Wu B, Thompson J, Ehrenfels BN, Ren S, Song A, Gelzleichter TR, Danilenko DM.

Am J Pathol. 2006 Feb;168(2):476-89.

21.

A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response.

Seshasayee D, Wang H, Lee WP, Gribling P, Ross J, Van Bruggen N, Carano R, Grewal IS.

J Biol Chem. 2004 Jul 16;279(29):30202-9. Epub 2004 May 15.

22.

NTB-A, a new activating receptor in T cells that regulates autoimmune disease.

Valdez PA, Wang H, Seshasayee D, van Lookeren Campagne M, Gurney A, Lee WP, Grewal IS.

J Biol Chem. 2004 Apr 30;279(18):18662-9. Epub 2004 Feb 26.

23.

APRIL-deficient mice have normal immune system development.

Varfolomeev E, Kischkel F, Martin F, Seshasayee D, Wang H, Lawrence D, Olsson C, Tom L, Erickson S, French D, Schow P, Grewal IS, Ashkenazi A.

Mol Cell Biol. 2004 Feb;24(3):997-1006.

24.

Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor.

Seshasayee D, Valdez P, Yan M, Dixit VM, Tumas D, Grewal IS.

Immunity. 2003 Feb;18(2):279-88.

25.

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.

Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin J, Starovasnik MA, Dixit VM.

Immunity. 2002 Oct;17(4):515-24.

26.

GATA-1- and FOG-dependent activation of megakaryocytic alpha IIB gene expression.

Gaines P, Geiger JN, Knudsen G, Seshasayee D, Wojchowski DM.

J Biol Chem. 2000 Nov 3;275(44):34114-21.

27.

Intron 1 elements promote erythroid-specific GATA-1 gene expression.

Seshasayee D, Geiger JN, Gaines P, Wojchowski DM.

J Biol Chem. 2000 Jul 28;275(30):22969-77.

28.
29.

Mechanisms of stem cell factor and erythropoietin proliferative co-signaling in FDC2-ER cells.

Joneja B, Chen HC, Seshasayee D, Wrentmore AL, Wojchowski DM.

Blood. 1997 Nov 1;90(9):3533-45.

PMID:
9345037
30.

Functional interaction of GATA1 with erythroid Krüppel-like factor and Sp1 at defined erythroid promoters.

Gregory RC, Taxman DJ, Seshasayee D, Kensinger MH, Bieker JJ, Wojchowski DM.

Blood. 1996 Mar 1;87(5):1793-801.

PMID:
8634425

Supplemental Content

Loading ...
Support Center